dm+d

Unassigned

New Medicines

Modufolin Colorectal cancer with liver metastases - before surgery

Information

Modufolin
New molecular entity
Isofol Medical
Isofol Medical

Development and Regulatory status

None
Phase II Clinical Trials
None

Category

R-enantiomer of folitixorin. Key active metabolite of all clinically used folate-based drugs used currently for cancer treatment, including folinic acid (leucovorin and levoleucovorin).
Colorectal cancer (cancer of the colon or rectum, or bowel cancer) is the fourth most common cancer in the UK, with over 41,000 new cases diagnosed each year. Survival rates have improved over time, with almost 60% of people diagnosed with colorectal cancer surviving for at least 5 years. Survival is linked to disease stage at presentation, with better survival the earlier the disease is detected and treated [1].
Colorectal cancer with liver metastases - before surgery
Intravenous